Journal of Genetic Syndromes & Gene Therapy
Open Access

Immunohistochemistry: A Powerful Tool for Tissue Proteins

Rogers Sergei^{* *}Correspondence: Rogers Sergei, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA, Email:

Author info »

Description

Immunohistochemistry (IHC) is a technique that allows the visualization and identification of specific proteins in tissue samples. This powerful tool has become an essential component in the field of pathology and biomedical research due to its ability to identify proteins within their cellular and tissue contexts. In this article, we will discuss the principles of immunohistochemistry, its applications, and its benefits.

Principles of immunohistochemistry

The principle of IHC is based on the use of antibodies to target specific proteins in tissue samples. Antibodies are proteins produced by the immune system that can recognize and bind to specific molecules, called antigens. In IHC, an antibody that is specific to the protein of interest is used to label the tissue sample. The antibody binds to the protein, forming an antibodyprotein complex, which can then be visualized using a detection system. The detection system used in IHC is typically based on an enzyme reaction that produces a visible signal. One of the most commonly used detection systems is the peroxidase reaction, which involves the use of an enzyme called Horseradish Peroxidase (HRP). When HRP is added to the tissue sample, it catalyzes a reaction that produces a colored product. This colored product can then be visualized under a microscope, allowing the identification of the protein of interest [1].

Applications of immunohistochemistry

IHC has a wide range of applications in both clinical and research settings. In clinical settings, IHC is used for diagnostic purposes, particularly in the diagnosis of cancer. By identifying specific proteins in tissue samples, IHC can help to distinguish between different types of cancer, guide treatment decisions, and predict patient outcomes. In research settings, IHC is used to investigate the role of specific proteins in biological processes. For example, researchers may use IHC to study the expression of a particular protein in different cell types or to investigate the effects of a drug on protein expression. IHC can also be used to visualize protein-protein interactions, which can provide insights into the mechanisms of complex biological processes [2, 3].

Benefits of immunohistochemistry

One of the main benefits of IHC is its ability to identify proteins within their cellular and tissue contexts. This allows researchers and clinicians to investigate the role of specific proteins in the normal functioning of tissues and in disease processes. IHC also allows for the identification of rare cell populations or subcellular structures that may not be visible using other techniques. Another benefit of IHC is its ability to provide both qualitative and quantitative information. By visualizing the protein of interest, IHC can provide qualitative information about its expression patterns and localization within tissues. Quantitative information can also be obtained by measuring the intensity of the staining signal or the percentage of positively stained cells. Despite its many advantages, IHC does have some limitations. One limitation is the potential for non-specific binding of antibodies to other proteins in the tissue sample, which can result in false positives. This can be minimized through careful selection of antibodies and optimization of staining conditions. IHC can also be combined with other techniques, such as fluorescence microscopy or electron microscopy, to provide additional information about the tissue or protein of interest. For example, by combining IHC with fluorescence microscopy, researchers can identify co-localization of proteins within a cell, providing insights into protein-protein interactions and signaling pathways [4].

Conclusion

Immunohistochemistry is a powerful technique that has become an essential tool in the fields of pathology and biomedical research. By allowing the visualization and identification of specific proteins in tissue samples, IHC has numerous applications in both clinical and research settings. Its ability to identify proteins within their cellular and tissue contexts, provide qualitative and quantitative information, and investigate the mechanisms of complex biological processes make IHC an invaluable tool for investigating tissue proteins. In addition to its wide range of applications, IHC also has several advantages over other protein detection techniques. For example, IHC can be performed on Formalin-Fixed, Paraffin-Embedded (FFPE) tissues, which are commonly used for archival purposes. This allows for the retrospective analysis of tissue samples, which can be invaluable in clinical research. Overall, immunohistochemistry is a powerful and versatile technique that has revolutionized the field of pathology and biomedical research. Its ability to identify and visualize specific proteins in tissue samples has numerous applications in both clinical and research settings, and its many advantages make it a valuable tool for investigating tissue proteins.

References

1. Stenos C, Kalafatakis K, Constantoulakis P, Zekiou K, Margoni A, Kardara P, et al. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene. J. clini lipidol. 2022;16(03):281-285.

   [Crossref] [Google Scholar]

2. Guenzel AJ, DeBarber A, Raymond K, Dhamija R. Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings. JIMD reports. 2021;59(1):3-9.

   [Crossref] [Google Scholar]

3. Nozue T, Higashikata T, Inazu A, Kawashiri MA, Nohara A, Kobayashi J,et al. Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis. Intern. Medici. 2010;49(12):1127-1131.

   [Crossref] [Google Scholar]

4. Stelten BM, Raal FJ, Marais AD, Riksen NP, Roeters van Lennep JE, et al. Cerebrotendinous xanthomatosis without neurological involvement. J. Int.Medi. 2021;290(5):1039-1047.

   [Crossref] [Google Scholar]